Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab

Clinical trial NCT00842699 · COMPLETED

Trial details

NCT number: NCT00842699
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Renal Transplantation

Start date: 2008-09-01
Primary completion: 2010-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.